Paciga M - Search Results

1

FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma.

Chuk MK, Chang JT, Theoret MR, Sampene E, He K, Weis SL, Helms WS, Jin R, Li H, Yu J, Zhao H, Zhao L, Paciga M, Schmiel D, Rawat R, Keegan P, Pazdur R. Chuk MK, et al. Among authors: paciga m. Clin Cancer Res. 2017 Oct 1;23(19):5666-5670. doi: 10.1158/1078-0432.CCR-16-0663. Epub 2017 Feb 24. Clin Cancer Res. 2017. PMID: 28235882 Clinical Trial.

2

FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.

Pai-Scherf L, Blumenthal GM, Li H, Subramaniam S, Mishra-Kalyani PS, He K, Zhao H, Yu J, Paciga M, Goldberg KB, McKee AE, Keegan P, Pazdur R. Pai-Scherf L, et al. Among authors: paciga m. Oncologist. 2017 Nov;22(11):1392-1399. doi: 10.1634/theoncologist.2017-0078. Epub 2017 Aug 23. Oncologist. 2017. PMID: 28835513 Free PMC article. Clinical Trial.

3

Macrophage-Derived Factors with the Potential to Contribute to Pathogenicity of HIV-1 and HIV-2: Role of CCL-2/MCP-1.

Gao C, Ouyang W, Kutza J, Grimm TA, Fields K, Lankford CSR, Schwartzkopff F, Paciga M, Stantchev T, Tiffany L, Strebel K, Clouse KA. Gao C, et al. Among authors: paciga m. Viruses. 2023 Oct 27;15(11):2160. doi: 10.3390/v15112160. Viruses. 2023. PMID: 38005838 Free PMC article.

4

Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.

Stantchev TS, Paciga M, Lankford CR, Schwartzkopff F, Broder CC, Clouse KA. Stantchev TS, et al. Among authors: paciga m. Retrovirology. 2012 Dec 3;9:97. doi: 10.1186/1742-4690-9-97. Retrovirology. 2012. PMID: 23206338 Free PMC article.

5

Tuberoinfundibular Peptide of 39 residues is required for germ cell development.

Usdin TB, Paciga M, Riordan T, Kuo J, Parmelee A, Petukova G, Camerini-Otero RD, Mezey E. Usdin TB, et al. Among authors: paciga m. Endocrinology. 2008 Sep;149(9):4292-300. doi: 10.1210/en.2008-0419. Epub 2008 May 15. Endocrinology. 2008. PMID: 18483145 Free PMC article.

6

Evidence for cross-talk between stanniocalcins.

Paciga M, James K, Gillespie JR, Wagner GF. Paciga M, et al. Can J Physiol Pharmacol. 2005 Nov;83(11):953-6. doi: 10.1139/y05-055. Can J Physiol Pharmacol. 2005. PMID: 16391703

7

Characterization of big stanniocalcin variants in mammalian adipocytes and adrenocortical cells.

Paciga M, Hirvi ER, James K, Wagner GF. Paciga M, et al. Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E197-205. doi: 10.1152/ajpendo.00581.2004. Epub 2005 Mar 1. Am J Physiol Endocrinol Metab. 2005. PMID: 15741242 Free article.

8

Regulation of luteal cell big stanniocalcin production and secretion.

Paciga M, DiMattia GE, Wagner GF. Paciga M, et al. Endocrinology. 2004 Sep;145(9):4204-12. doi: 10.1210/en.2003-1613. Epub 2004 Jun 10. Endocrinology. 2004. PMID: 15192041

9

Targeting of big stanniocalcin and its receptor to lipid storage droplets of ovarian steroidogenic cells.

Paciga M, McCudden CR, Londos C, DiMattia GE, Wagner GF. Paciga M, et al. J Biol Chem. 2003 Dec 5;278(49):49549-54. doi: 10.1074/jbc.M307302200. Epub 2003 Sep 25. J Biol Chem. 2003. PMID: 14512426 Free article.

10

Ovarian stanniocalcin is structurally unique in mammals and its production and release are regulated through the luteinizing hormone receptor.

Paciga M, Watson AJ, DiMattia GE, Wagner GF. Paciga M, et al. Endocrinology. 2002 Oct;143(10):3925-34. doi: 10.1210/en.2002-220337. Endocrinology. 2002. PMID: 12239104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters